DST: If you want
the .pdf of the article at the URL below, I will need your current email address.
http://
www.haworthpress.com/store/ArticleAbstract.asp?sid=F1AJ71WMKCP48HTMPW51HDT2GP 7Q5DS7&ID=90566
Isolation of the VNO was initially linked to a patented process/delivery system as I recall. This was seen by many
researchers to be a 2nd red flag with regard to findings that could not be independently replicated on picogram
amounts of "active" compounds.
In the most recently reported published findings: "Thirty milligrams of AND...,
were deposited in pure form into a 60ml... opaque jar, to be smelled by participants."
From a human VNO
activation to effect approach, it's picogram amounts and unreplicated data. From the more current non-VNO approach
we're seeing effects with (let me check my math... uh?) -- a lot more of the compound.
It's hard for me to
imagine any woman ever being naturally exposed to 20 sniffs of 30 milligrams of AND. So, while it's good to see
reports of hormonal, mood, and arousal change, I'm not sure how all this translates to product development.
Seems we've now gone from activating the VNO with picogram amounts of AND, blocking the VNO and showing that it
makes a difference (though the data may not be published or replicated) and finally come round to attacking the
human olfactory/pheromonal processing system (sans VNO mention?) with massive doses of chemical.
James V.
Kohl
author of a less recent review at:
http://www.nel.edu/22_5/NEL220501R01_Review.htm
Bookmarks